Publication | Open Access
Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival
46
Citations
41
References
2017
Year
Histone ModificationsMycobacterium Tuberculosis InfectionMicrobial PathogensAdaptive Immune SystemEpigenetic ChangeInnate Immune SystemImmunologyImmune RegulationCd4 T Cell ResponsesInnate ImmunityImmune SystemEpigeneticsInflammationMycobacterium TuberculosisSet8-nqo1/trxr1 AxisImmune SurveillanceHumoral ImmunityT Cell ImmunityImmune FunctionHost-microbe InteractionGene ExpressionEpigenetic RegulationCell BiologyChromatinChromatin RemodelingImmune Cell DevelopmentEpigenomicsMycobacterial SurvivalMicrobiologyCellular Immune ResponseMedicineGenome Editing
NQO1 and TRXR1 are important host reductases implicated in the regulation of inflammation and apoptosis. Although the transcriptional machinery governing these processes have been extensively investigated, the associated epigenetic regulatory events remain unclear. Here, we report that SET8, a histone H4 lysine 20 monomethylase (H4K20me1), is highly induced during Mycobacterium tuberculosis infection that orchestrates immune evasion strategies through the induction of NQO1 and TRXR1 in vivo. SET8, along with FoxO3a, mediates an active NQO1-PGC1-α complex, which promotes the anti-inflammatory M2 macrophage phenotype, and assists TRXR1-regulated arrest of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Strikingly, the loss-of-function analysis in an in vivo mouse tuberculosis model further corroborated the pivotal role of SET8-responsive NQO1 and TRXR1 in mycobacterial survival. Thus, augmenting host immune responses against Mycobacterium tuberculosis by harnessing the SET8-NQO1/TRXR1 axis with its specific and potent inhibitors could lead to promising host-directed therapeutic adjuvants for tuberculosis treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1